Bfsg, LLC Novo Nordisk A S Transaction History

Bfsg, LLC

  • $843 Million
  • Q3 2024

A detailed history of Bfsg, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bfsg, LLC holds 86,617 shares of NVO stock, worth $9.18 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
86,617
Previous 43,955 97.06%
Holding current value
$9.18 Million
Previous $6.27 Million 64.38%
% of portfolio
1.22%
Previous 0.81%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$119.07 - $145.42 $5.08 Million - $6.2 Million
42,662 Added 97.06%
86,617 $10.3 Million
Q2 2024

Jul 29, 2024
SELL
$122.71 - $146.91 $317,818 - $380,496
-2,590 Reduced 5.56%
43,955 $6.27 Million
Q1 2024

Apr 23, 2024
SELL
$102.11 - $135.92 $21,340 - $28,407
-209 Reduced 0.45%
46,545 $5.98 Million
Q4 2023

Feb 01, 2024
BUY
$87.78 - $105.45 $3,160 - $3,796
36 Added 0.08%
46,754 $4.84 Million
Q3 2023

Oct 20, 2023
BUY
$90.94 - $199.54 $2.27 Million - $4.99 Million
24,998 Added 115.09%
46,718 $4.25 Million
Q2 2023

Aug 07, 2023
BUY
$155.98 - $172.65 $511,926 - $566,637
3,282 Added 17.8%
21,720 $3.52 Million
Q1 2023

May 10, 2023
SELL
$132.34 - $159.14 $3,970 - $4,774
-30 Reduced 0.16%
18,438 $2.93 Million
Q4 2022

Feb 01, 2023
SELL
$102.55 - $135.33 $43,583 - $57,515
-425 Reduced 2.25%
18,468 $2.5 Million
Q3 2022

Nov 07, 2022
SELL
$95.28 - $116.93 $40,970 - $50,279
-430 Reduced 2.23%
18,893 $1.88 Million
Q2 2022

Aug 04, 2022
SELL
$103.24 - $121.81 $26,222 - $30,939
-254 Reduced 1.3%
19,323 $2.15 Million
Q1 2022

May 04, 2022
SELL
$93.1 - $112.54 $83,231 - $100,610
-894 Reduced 4.37%
19,577 $2.17 Million
Q4 2021

Jan 24, 2022
SELL
$95.88 - $117.08 $110,741 - $135,227
-1,155 Reduced 5.34%
20,471 $2.29 Million
Q3 2021

Nov 03, 2021
SELL
$84.42 - $106.62 $28,280 - $35,717
-335 Reduced 1.53%
21,626 $2.08 Million
Q2 2021

Jul 29, 2021
SELL
$67.66 - $84.76 $73,952 - $92,642
-1,093 Reduced 4.74%
21,961 $1.84 Million
Q1 2021

Apr 26, 2021
SELL
$67.06 - $75.82 $375,133 - $424,137
-5,594 Reduced 19.53%
23,054 $1.55 Million
Q4 2020

Jan 26, 2021
SELL
$63.89 - $73.8 $36,097 - $41,697
-565 Reduced 1.93%
28,648 $2 Million
Q3 2020

Nov 04, 2020
SELL
$63.69 - $70.22 $53,308 - $58,774
-837 Reduced 2.79%
29,213 $2.03 Million
Q2 2020

Jul 22, 2020
SELL
$58.54 - $67.94 $5,854 - $6,794
-100 Reduced 0.33%
30,050 $1.97 Million
Q1 2020

Apr 27, 2020
SELL
$49.46 - $64.78 $18,596 - $24,357
-376 Reduced 1.23%
30,150 $1.82 Million
Q4 2019

Jan 29, 2020
SELL
$49.86 - $58.26 $29,916 - $34,956
-600 Reduced 1.93%
30,526 $1.77 Million
Q3 2019

Oct 25, 2019
SELL
$47.54 - $53.43 $139,292 - $156,549
-2,930 Reduced 8.6%
31,126 $1.61 Million
Q2 2019

Jul 30, 2019
SELL
$46.79 - $52.47 $128,906 - $144,554
-2,755 Reduced 7.48%
34,056 $1.74 Million
Q1 2019

Apr 18, 2019
SELL
$46.36 - $52.63 $63,281 - $71,839
-1,365 Reduced 3.58%
36,811 $1.93 Million
Q4 2018

Jan 24, 2019
SELL
$41.54 - $47.25 $89,934 - $102,296
-2,165 Reduced 5.37%
38,176 $1.76 Million
Q3 2018

Oct 18, 2018
SELL
$46.76 - $51.24 $30,440 - $33,357
-651 Reduced 1.59%
40,341 $1.9 Million
Q2 2018

Jul 31, 2018
SELL
$44.29 - $50.42 $1,993 - $2,268
-45 Reduced 0.11%
40,992 $1.89 Million
Q1 2018

May 08, 2018
BUY
$48.49 - $58.14 $12,364 - $14,825
255 Added 0.63%
41,037 $2.02 Million
Q4 2017

Jan 23, 2018
SELL
$47.53 - $53.73 $51,332 - $58,028
-1,080 Reduced 2.58%
40,782 $2.19 Million
Q3 2017

Oct 12, 2017
SELL
$41.15 - $49.22 $24,484 - $29,285
-595 Reduced 1.4%
41,862 $2.02 Million
Q2 2017

Aug 10, 2017
BUY
N/A
42,457
42,457 $1.82 Million

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $239B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email